Geisinger Partners With Indivumed for Personalized Medicine Initiative

Geisinger Health System announced plans to partner with Indivumed, a leading provider of services enabling individualized cancer therapy, a relationship that will afford Geisinger patients access to advanced cancer treatment and clinical trials.

“This exciting initiative with Indivumed, a company recognized the world over as a leader in the field of biobanking and translational research, will give Geisinger patients access to the most advanced cancer therapeutics in the country,” said Glenn D. Steele Jr., M.D., Ph.D., president and chief executive officer at Geisinger Health System.